Review Registration - Organization

This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.

Registration ID: 29641853
Submitted by lobbyist on: October 24, 2016 10:17:52 AM
Accepted by Registrar on: October 24, 2016 11:38:36 AM

Designated Filer Information

Miller, Ronnie  
7070 Mississauga Rd  
Mississauga, ON, L5N 5M8
905-542-5555
Canada  

Organization Information

Hoffmann-La Roche Limited  
Hoffmann-La Roche Limited deals with the healthcare system in the prevention, screening, diagnosis, treatment and management of acute and long-term disease and supports leading research and development including clinical research, clinical trials and genetic research.
7070 Mississauga Rd  
Mississauga, ON, L5N 5M8
905-285-7810
Canada  

Relevant Affiliates


Type:

Business Name Mailing Address Contact Information
Hoffmann-La Roche Limited Grenzacherstrasse 124,
Basle,

Switzerland
Phone: 9052857810

Government or Government Agency Funding


The organization does not receive any funding from a government or government agency.

Other Controlling or Directing Interests

The organization has no other controlling or directing interests.

Active Registration Period

October 24, 2016  
April 22, 2017  

Organization's In-House Lobbyists

 



Name: Coventry, Bryn
 
January 11, 2017  
Inactivation Date: April 26, 2017

BC Public Office Background

This individual has not held any public office positions in BC.

Lobbying Activities

Health

Development, establishment, amendment or termination of any program, policy or decision

Advocating changes to the annual provincial drug budget asit relates to the biopharmaceutical industry. Biologics, genetic therapies and subsequent entry biologics (SEBs) as it relates to policies affecting the review, approval, and process of submissions. Lobbying regarding the general improvement of biopharmaceutical business environment in BC as it relates to pandemic planning; antivirals, oncology, rheumatology, urgent care, personalized healthcare, virology and clinical research.

Target Contacts

Target Type Name Title or Constituency Date Added
Minister Stilwell, Michelle Minister of Social Development and Social Innovation January 11, 2017
Minister Virk, Amrik Minister of Technology, Innovation and Citizens' Services January 11, 2017

Name: Kallmeyer, Ian
 
October 24, 2016  
Inactivation Date: April 26, 2017

BC Public Office Background

This individual has not held any public office positions in BC.

Lobbying Activities

Health

Development, establishment, amendment or termination of any program, policy or decision

Advocating changes to the annual provincial drug budget as it relates to the biopharmaceutical industry. Biologics, Genetic Therapies, and Subsequent Entry Biologics (SEBs) as it relates to the policies affecting the review, approval, and process of submissions. Lobbying regarding the general improvement of BioPharmaceutical business environment in BC as it relates to pandemic planning & antivirals, Oncology, Rheumatology, Urgent Care, Personalized Healthcare, Virology, and Clinical Research

Target Contacts

Target Type Name Title or Constituency Date Added
Minister Stilwell, Michelle Minister of Social Development and Social Innovation October 24, 2016
Minister Virk, Amrik Minister of Technology, Innovation and Citizens' Services October 24, 2016

Name: Kelley, Michael
 
October 24, 2016  
Inactivation Date: April 26, 2017

BC Public Office Background

This individual has not held any public office positions in BC.

Lobbying Activities

Health

Development, establishment, amendment or termination of any program, policy or decision

Advocating changes to the annual provincial drug budget as it relates to the biopharmaceutical industry. Biologics, Genetic Therapies, and Subsequent Entry Biologics (SEBs) as it relates to the policies affecting the review, approval, and process of submissions. Lobbying regarding the general improvement of BioPharmaceutical business environment in BC as it relates to pandemic planning & antivirals, Oncology, Rheumatology, Urgent Care, Personalized Healthcare, Virology, and Clinical Research

Target Contacts

Target Type Name Title or Constituency Date Added
Minister Stilwell, Michelle Minister of Social Development and Social Innovation October 24, 2016
Minister Virk, Amrik Minister of Technology, Innovation and Citizens' Services October 24, 2016

Name: Miller, Ronnie
 
October 24, 2016  
Inactivation Date: April 26, 2017

BC Public Office Background

This individual has not held any public office positions in BC.

Lobbying Activities

Health

Development, establishment, amendment or termination of any program, policy or decision

Advocating changes to the annual provincial drug budget as it relates to the biopharmaceutical industry. Biologics, Genetic Therapies, and Subsequent Entry Biologics (SEBs) as it relates to the policies affecting the review, approval, and process of submissions. Lobbying regarding the general improvement of BioPharmaceutical business environment in BC as it relates to pandemic planning & antivirals, Oncology, Rheumatology, Urgent Care, Personalized Healthcare, Virology, and Clinical Research

Target Contacts

Target Type Name Title or Constituency Date Added
Minister Stilwell, Michelle Minister of Social Development and Social Innovation October 24, 2016
Minister Virk, Amrik Minister of Technology, Innovation and Citizens' Services October 24, 2016
Public Agency Provincial Health Services Authority October 24, 2016

Name: Pougnet, Jennifer
 
October 24, 2016  
Inactivation Date: April 26, 2017

BC Public Office Background

This individual has not held any public office positions in BC.

Lobbying Activities

Health

Development, establishment, amendment or termination of any program, policy or decision

Advocating changes to the annual provincial drug budget as it relates to the biopharmaceutical industry. Biologics, Genetic Therapies, and Subsequent Entry Biologics (SEBs) as it relates to the policies affecting the review, approval, and process of submissions. Lobbying regarding the general improvement of BioPharmaceutical business environment in BC as it relates to pandemic planning & antivirals, Oncology, Rheumatology, Urgent Care, Personalized Healthcare, Virology, and Clinical Research

Target Contacts

Target Type Name Title or Constituency Date Added
Minister Stilwell, Michelle Minister of Social Development and Social Innovation October 24, 2016
Minister Virk, Amrik Minister of Technology, Innovation and Citizens' Services October 24, 2016

Name: Sungaila, Ina
 
October 24, 2016  
Inactivation Date: April 26, 2017

BC Public Office Background

This individual has not held any public office positions in BC.

Lobbying Activities

Health

Development, establishment, amendment or termination of any program, policy or decision

Advocating changes to the annual provincial drug budget as it relates to the biopharmaceutical industry. Biologics, Genetic Therapies, and Subsequent Entry Biologics (SEBs) as it relates to the policies affecting the review, approval, and process of submissions. Lobbying regarding the general improvement of BioPharmaceutical business environment in BC as it relates to pandemic planning & antivirals, Oncology, Rheumatology, Urgent Care, Personalized Healthcare, Virology, and Clinical Research

Target Contacts

Target Type Name Title or Constituency Date Added
Minister Stilwell, Michelle Minister of Social Development and Social Innovation October 24, 2016
Minister Virk, Amrik Minister of Technology, Innovation and Citizens' Services October 24, 2016